Moderna
MRNA
#1211
Rank
HK$153.64 B
Marketcap
HK$393.23
Share price
0.84%
Change (1 day)
49.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of September 2025 : HK$94.88 Billion

According to Moderna 's latest financial reports the company's total assets are HK$94.88 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$109.79 B-23.71%
2023-12-31HK$143.90 B-28.77%
2022-12-31HK$202.03 B5.03%
2021-12-31HK$192.35 B238.2%
2020-12-31HK$56.87 B359.49%
2019-12-31HK$12.37 B-19.44%
2018-12-31HK$15.36 B81.34%
2017-12-31HK$8.47 B-22.9%
2016-12-31HK$10.98 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
HK$1.557 T 1,541.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$867.53 B 814.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$1.012 T 967.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$0.58 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
HK$58.08 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
HK$38.83 B-59.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
HK$12.54 B-86.78%๐Ÿ‡บ๐Ÿ‡ธ USA